URMC Secures $6 Million for Study on Slowing Early Parkinson's

Wednesday, September 2, 2015

Source: Rochester Business Journal

The University of Rochester Medical Center will receive $6 million for a clinical study on slowing early Parkinson’s disease.

It has been has been selected as the coordinating center for data collection in a 60-site clinical investigation of the drug Inosine.

David Oakes, a professor in the Department of Biostatistics and Computational Biology, will facilitate data coordination with study chair Michael Schwarzschild, a neurobiologist at Massachusetts General Hospital. The National Institute of Neurological Disorders and Stroke funded the five-year, $26 million project.

View All News »